Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NRXP
#4084
NRX Pharmaceuticals, Inc. Common Stock
2.510
0
USD
+10.09%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+10.09%
Monthly Change
+30.05%
6 month change
+41.01%
Year Change
+41.01%
Previous Close
2.280
0
Open
2.489
4
Bid
Ask
Low
2.485
0
High
2.528
2
Volume
79
Markets
US Stock Market
Healthcare
NRXP
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2025
TTM
Key stats
Total common shares outstanding
6.66 M
7.16 M
9.57 M
16.92 M
33.07 M
—
Valuation ratios
Enterprise value
290.94 M
66.53 M
52.32 M
42.35 M
82.45 M
288.25 M
Price to earnings ratio
-2.41
-2.02
-1.25
-0.93
-2.03
-6.75
Price to sales ratio
1 853.44
—
—
—
47.35
—
Price to cash flow ratio
-5.95
-2
-1.75
-2.2
-4.11
-20.82
Price to book ratio
10.78
10.74
-3.22
-1.01
-3.64
-5.37
Enterprise value to EBITDA ratio
-2.52
—
—
-1.93
-5.03
—
Profitability ratios
Return on assets %
-2.84
-1.54
-4.12
-6.88
-2.21
-4.73
Return on equity %
-4.47
-5.37
2.57
1.08
1.8
0.92
Return on invested capital %
-5 927.61
-1 836.06
-1 184.05
-631.58
-353.51
-245.62
Gross margin %
100
—
—
—
58.78
—
Operating margin %
-95.7 K
—
—
—
-1 324.41
—
EBITDA margin %
-95.6 K
—
—
—
-1 326.86
—
Net margin %
-76.91 K
—
—
—
-2 336.49
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.74
1.66
0.36
0.15
0.31
0.94
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
—
—
0
0.15
0.09
Solvency ratios
Debt to assets ratio
—
—
1.25
1.8
0.05
3.96
Debt to equity ratio
—
—
-0.78
-0.28
-0.04
-1.06
Long term debt to total assets ratio
—
—
1.25
1.8
0
3.89
Long term debt to total equity ratio
—
—
-0.78
-0.28
0
-1.01
Per share metrics
Operating cash flow per share
-8.04
-6.04
-2.86
-1
-0.66
-0.44
EBIT per share
-24.65
—
—
-1.74
-0.76
-0.51
EBITDA per share
-24.65
—
—
-1.74
-0.76
-0.52
Total debt per share
—
—
1.21
0.62
0.03
0.86
Cash per share
5.88
3.05
0.61
0.14
0.36
0.71
Net current asset value per share
6.97
3.92
0.91
0.31
0.42
1.03
Tangible book value per share
4.43
1.13
-1.55
-2.18
-0.87
-3.5
Working capital per share
4.43
1.55
-1.61
-1.74
-0.92
-3.57
Book value per share
4.43
1.13
-1.55
-2.18
-0.74
-3.26
News
NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings Estimates
NRx Pharmaceuticals, Inc. (NRXP) Shareholder/Analyst Call Prepared Remarks Transcript
NRx Pharmaceuticals receives FDA bioequivalence approval notice
NRx Pharmaceuticals receives FDA guidance on NRX-100 drug application
VTSAX vs. VTI: Which Vanguard Fund Should You Buy in 2026? - TipRanks.com
H.C. Wainwright raises NRx Pharmaceuticals stock price target to $45
NRx Pharmaceuticals appoints Joshua Brown as chief medical officer
NRx Builds Momentum From FDA Progress To Strategic Expansion - NRX Pharmaceuticals (NASDAQ:NRXP)
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/23/26 - TipRanks.com
NRx Pharmaceuticals appoints Joseph M. Casper as chief operating officer
New Strong Sell Stocks for January 27th
H.C. Wainwright reiterates Buy rating on NRx Pharmaceuticals stock at $40